These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 24471566)
1. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011). Tardy-Guidollet V; Menassa R; Costa JM; David M; Bouvattier-Morel C; Baumann C; Houang M; Lorenzini F; Philip N; Odent S; Guichet A; Morel Y J Clin Endocrinol Metab; 2014 Apr; 99(4):1180-8. PubMed ID: 24471566 [TBL] [Abstract][Full Text] [Related]
2. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels. Dörr HG; Sippell WG J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074 [TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. Cerame BI; Newfield RS; Pascoe L; Curnow KM; Nimkarn S; Roe TF; New MI; Wilson RC J Clin Endocrinol Metab; 1999 Sep; 84(9):3129-34. PubMed ID: 10487675 [TBL] [Abstract][Full Text] [Related]
5. [Prenatal diagnosis and treatment of adrenogenital syndrome. Prevent virilization of female fetuses]. Lajic S; Bui TH; Holst M; Ritzén M; Wedell A Lakartidningen; 1997 Dec; 94(50):4781-6. PubMed ID: 9445959 [TBL] [Abstract][Full Text] [Related]
6. New developments in prenatal diagnosis of congenital adrenal hyperplasia. Kazmi D; Bailey J; Yau M; Abu-Amer W; Kumar A; Low M; Yuen T J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):121-123. PubMed ID: 27378492 [TBL] [Abstract][Full Text] [Related]
7. Preventing female virilisation in congenital adrenal hyperplasia: The controversial role of antenatal dexamethasone. Heland S; Hewitt JK; McGillivray G; Walker SP Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):225-32. PubMed ID: 26661642 [TBL] [Abstract][Full Text] [Related]
8. Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone. Wallensteen L; Zimmermann M; Thomsen Sandberg M; Gezelius A; Nordenström A; Hirvikoski T; Lajic S J Clin Endocrinol Metab; 2016 Oct; 101(10):3838-3846. PubMed ID: 27482827 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety. Miller WL J Urol; 1999 Aug; 162(2):537-40. PubMed ID: 10411085 [TBL] [Abstract][Full Text] [Related]
10. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Wedell A; Lajic S J Clin Endocrinol Metab; 2007 Feb; 92(2):542-8. PubMed ID: 17148562 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia. Wallensteen L; Karlsson L; Messina V; Gezelius A; Sandberg MT; Nordenström A; Hirvikoski T; Lajic S Horm Behav; 2018 Feb; 98():219-224. PubMed ID: 29410007 [TBL] [Abstract][Full Text] [Related]
12. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. Pang S; Clark AT; Freeman LC; Dolan LM; Immken L; Mueller OT; Stiff D; Shulman DI J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017 [TBL] [Abstract][Full Text] [Related]
13. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Meyer-Bahlburg HF; Dolezal C; Haggerty R; Silverman M; New MI Eur J Endocrinol; 2012 Jul; 167(1):103-10. PubMed ID: 22549088 [TBL] [Abstract][Full Text] [Related]
14. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. Carlson AD; Obeid JS; Kanellopoulou N; Wilson RC; New MI J Steroid Biochem Mol Biol; 1999; 69(1-6):19-29. PubMed ID: 10418977 [TBL] [Abstract][Full Text] [Related]
15. Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: up-date 88 of the French multicentric study. Forest MG; Bétuel H; David M Endocr Res; 1989; 15(1-2):277-301. PubMed ID: 2667968 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive prenatal testing for fetal sex determination: is ultrasound still relevant? Colmant C; Morin-Surroca M; Fuchs F; Fernandez H; Senat MV Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):197-204. PubMed ID: 24094458 [TBL] [Abstract][Full Text] [Related]
17. [Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 9 treated pregnancies]. Nivelon JL; Chouchane M; Forest MG; Morel Y; Huet F; Nivelon-Chevallier A; François C Ann Pediatr (Paris); 1993 Sep; 40(7):421-5. PubMed ID: 7902059 [TBL] [Abstract][Full Text] [Related]
18. Prenatal Diagnosis of Congenital Adrenal Hyperplasia. Yau M; Khattab A; New MI Endocrinol Metab Clin North Am; 2016 Jun; 45(2):267-81. PubMed ID: 27241964 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of sexual ambiguity in children with 21-hydroxylase deficiency by treatment in utero]. Forest MG; David M Pediatrie; 1992; 47(5):351-7. PubMed ID: 1331950 [TBL] [Abstract][Full Text] [Related]
20. An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia. New MI; Abraham M; Yuen T; Lekarev O Semin Reprod Med; 2012 Oct; 30(5):396-9. PubMed ID: 23044876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]